Concepedia

Maurizio Mangolini

MM

Statistics

Publications

7

Citations

329

H-Index

7

Active since

2013

Affiliations

University of Cambridge(Current)

Wellcome/MRC Cambridge Stem Cell Institute

Heidelberg University

University College London

German Cancer Research Center

Maurizio Mangolini is an author at University of Cambridge specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2013–2022

7

Publications

7

Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia

Maurizio Mangolini, Frederik Götte, A. P. Moore et al. · Nature Communications · 2018 · 76 citations · Full text

, , +17

Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia

Junyan Lu, Ester Cannizzaro, Fabienne Meier‐Abt et al. · Nature Cancer · 2021 · 62 citations · Full text

, , +17

STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia

Maurizio Mangolini, Jasper de Boer, Vanessa Walf-Vorderwülbecke et al. · Blood · 2013 · 46 citations

, , +7

The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis

Hikari Osaki, Vanessa Walf-Vorderwülbecke, Maurizio Mangolini et al. · Leukemia · 2013 · 42 citations

, , +11

MYC sensitises cells to apoptosis by driving energetic demand

Joy Edwards-Hicks, Huizhong Su, Maurizio Mangolini et al. · Nature Communications · 2022 · 38 citations · Full text

, , +17

1–5 of 7